To further deepen the possible association between Glo1 and PD-L1 in mPCa, we also evaluated, at mRNA and protein level, the expression of both molecules in biopsy samples obtained from metastatic (n = 30, stage M1) and non-metastatic PCa (n = 30 of which 15 stage pT2, cancer confined to the prostate and 15 stage pT3, extra-prostatic extension and/or seminal vesicle involvement) patients, whose characteristics were previously described [25]. Here, GLO1 is linked to cancer.